Incorporating external evidence on between‐trial heterogeneity in network meta‐analysis
暂无分享,去创建一个
Dan Jackson | Ian R White | Rebecca M Turner | Clara P Domínguez-Islas | Kirsty M Rhodes | I. White | K. Rhodes | R. Turner | D. Jackson
[1] Matt Simpson,et al. Bayesian inference for a covariance matrix , 2014, 1408.4050.
[2] Guobing Lu,et al. Modeling between-trial variance structure in mixed treatment comparisons. , 2009, Biostatistics.
[3] Xiao-Li Meng,et al. Modeling covariance matrices in terms of standard deviations and correlations, with application to shrinkage , 2000 .
[4] G. Lu,et al. Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.
[5] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[6] Kristian Thorlund,et al. Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution? , 2013, BMC Medical Research Methodology.
[7] Simon G Thompson,et al. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews , 2012, International journal of epidemiology.
[8] A Whitehead,et al. Borrowing strength from external trials in a meta-analysis. , 1996, Statistics in medicine.
[9] Alex J. Sutton,et al. Evidence Synthesis for Decision Making 2 , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[10] Andrew W Lee,et al. Review of mixed treatment comparisons in published systematic reviews shows marked increase since 2009. , 2014, Journal of clinical epidemiology.
[11] Rebecca M Turner,et al. Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis , 2011, BMC medical research methodology.
[12] G. Lu,et al. Assessing Evidence Inconsistency in Mixed Treatment Comparisons , 2006 .
[13] Christopher H. Schmid,et al. Characteristics of Networks of Interventions: A Description of a Database of 186 Published Networks , 2014, PloS one.
[14] Dan Jackson,et al. Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis , 2014, Statistics in medicine.
[15] Julian P T Higgins,et al. Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis , 2014, BMJ Open.
[16] Jeremy E. Oakley,et al. Incorporating Genuine Prior Information about Between-Study Heterogeneity in Random Effects Pairwise and Network Meta-analyses , 2017, Medical decision making : an international journal of the Society for Medical Decision Making.
[17] D. Bates,et al. Mixed-Effects Models in S and S-PLUS , 2001 .
[18] V. Hasselblad,et al. Meta-analysis of Multitreatment Studies , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[19] Georgia Salanti,et al. Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.
[20] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[21] Rebecca M. Turner,et al. Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data , 2015, Journal of clinical epidemiology.
[22] Andrew Thomas,et al. The BUGS project: Evolution, critique and future directions , 2009, Statistics in medicine.
[23] Tom Leonard,et al. Bayesian Inference for a Covariance Matrix , 1992 .